title: Simultaneous generation of nitric oxide and superoxide by inflammatory cells in rats.
abstract: It has recently been shown that peroxynitrite anion is a powerful oxidant than can initiate lipid peroxidation. As this oxidant is the product of the reaction between nitric oxide and superoxide, we have studied whether cells isolated from an inflammatory exudate can release both radicals simultaneously under physiological conditions. The carrageenin-induced granuloma model in rats was used. Cells from the inflammatory pouch were stimulated with opsonized zymosan in the absence or in the presence of exogenous L-arginine. Nitric oxide production without exogenous L-arginine was detectable after 15 min (0.29 nmol NO2-) and increased with time (1.65 nmol NO2- at 4 h). When nitrite released from cells was expressed as a rate a burst was shown in the first few minutes. Between 0 and 15 min, cells produced NO2- at the following rates: 20 pmol NO2-/1 x 10(6) cells/min without exogenous L-arginine and 83 pmol NO2-/1 x 10(6) cells/min with exogenous L-arginine. Production was further stimulated with opsonized zymosan (92 pmol NO2-/1 x 10(6) cells/min), and inhibited by L-NMMA and L-NIO. The production of superoxide increased for up to 2 h and then stabilized. A significant increase in nitrite was observed in the presence of SOD, whereas L-NIO increased superoxide generation. These results suggest that peroxynitrite anion may be formed by inflammatory cells.
authors.affiliation: Unitat de Fisiologia, Facultat de Biologia, Universitat de Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Ródenas
authors.forename: M T
authors.initials: MT
authors.lastname: Mitjavila
authors.forename: T
authors.initials: T
authors.lastname: Carbonell
mesh_terms: D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D002351:Carrageenan; D002470:Cell Survival / Q000187:drug effects; D006099:Granuloma / Q000139:chemically induced / Q000503:physiopathology; D066298:In Vitro Techniques; D007249:Inflammation / Q000503:physiopathology*; D007700:Kinetics; D007962:Leukocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013481:Superoxides / Q000378:metabolism*; D013997:Time Factors; D015054:Zymosan / Q000494:pharmacology; D019323:omega-N-Methylarginine
chemical_list: D013481:Superoxides; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; C065027:N(G)-iminoethylornithine; D002351:Carrageenan; D015054:Zymosan; D001120:Arginine; D009952:Ornithine